Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Eutropics receives NCI contract to develop predictive tests for personalized AML treatment

Sep. 29, 2014

FDA approves T2Candida Panel and T2Dx Instrument for detection of Candida

Sep. 26, 2014

Navidea awarded NIH grant for evaluation of Lymphoseek in cervical cancer

Sep. 26, 2014

Pocket consortium updates on tuberculosis diagnostic device

Sep. 22, 2014

Lymphoseek awarded U.S. orphan drug designation for head and neck cancers

Sep. 19, 2014

BARDA contract supports InDevR's development of FluChip-8G influenza diagnostic

Sep. 18, 2014

OncoCyte to use Abcodia's serum bank to validate its PanC-Dx cancer diagnostic

Sep. 18, 2014

Amarantus BioScience completes enrollment in Alzheimer's disease blood test trial

Sep. 17, 2014

VolitionRx reports topline results from colorectal screening study with NuQ test

Sep. 16, 2014

FDA approves Pleximmune to predict transplant rejection in children

Sep. 15, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...